Journal
CURRENT OPINION IN IMMUNOLOGY
Volume 72, Issue -, Pages 178-189Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2021.04.010
Keywords
-
Categories
Funding
- Yale University
- Cancer Research Institute
- Mathers Foundation
- NIAIDN.I.H.
Ask authors/readers for more resources
Activated PI3K-delta Syndrome (APDS) is an immune deficiency disorder caused by genetic mutations, leading to early onset immunodeficiency, recurrent infections, lymphadenopathy, and autoimmunity. Patients typically require treatment with immunomodulatory agents and may necessitate hematopoietic stem cell transplants in some cases.
Activated PI3K-delta Syndrome (APDS), also called PI3K-delta activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency (PASLI), is an autosomal dominant disorder caused by inherited or de novo gain-of-function mutations in one of two genes encoding subunits of the phosphoinositide-3-kinase delta (PI3Kd) complex. This largely leukocyte-restricted protein complex regulates cell growth, activation, proliferation, and survival. Patients who harbor these mutations have early onset immunodeficiency with recurrent infections, lymphadenopathy, and autoimmunity. The most common infection susceptibilities are sinopulmonary (encapsulated bacteria) and herpesviruses. Multiple defects in both innate and adaptive immune function are responsible for this phenotype. Apart from anti-microbial prophylaxis and immunoglobulin replacement, patients are treated with a variety of immunomodulatory agents and some have needed hematopoietic stem cell transplants. Here, we highlight the spectrum of infections, immune defects, and therapy options in this inborn error of immunity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available